B-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
19
Total Value
116734593
Accession Number
0001420506-25-001152
Form Type
13F-HR
Manager Name
B-Group
Data Enrichment
89% identified
17 identified2 unidentified

Holdings

19 positions • $116.7M total value
Manager:
Search and click to pin securities to the top
ADMA BIOLOGICS, INC.
Shares:2.3M
Value:$46.0M
% of Portfolio:39.4% ($46.0M/$116.7M)
INSMED Inc
Shares:262.5K
Value:$20.0M
% of Portfolio:17.2% ($20.0M/$116.7M)
Zai Lab Ltd
Shares:400.0K
Value:$14.5M
% of Portfolio:12.4% ($14.5M/$116.7M)
Akero Therapeutics, Inc.
Shares:242.5K
Value:$9.8M
% of Portfolio:8.4% ($9.8M/$116.7M)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:1.5M
Value:$5.0M
% of Portfolio:4.3% ($5.0M/$116.7M)
Cellectis S.A.
Shares:3.3M
Value:$4.0M
% of Portfolio:3.5% ($4.0M/$116.7M)
Aura Biosciences, Inc.
Shares:472.6K
Value:$2.8M
% of Portfolio:2.4% ($2.8M/$116.7M)
Sight Sciences, Inc.
Shares:833.6K
Value:$2.0M
% of Portfolio:1.7% ($2.0M/$116.7M)
ASSEMBLY BIOSCIENCES, INC.
Shares:200.0K
Value:$1.9M
% of Portfolio:1.6% ($1.9M/$116.7M)
Taysha Gene Therapies, Inc.
Shares:1.3M
Value:$1.7M
% of Portfolio:1.5% ($1.7M/$116.7M)
Ultragenyx Pharmaceutical Inc.
Shares:47.5K
Value:$1.7M
% of Portfolio:1.5% ($1.7M/$116.7M)
BioNTech SE
Shares:15.0K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$116.7M)
90400D908
Shares:37.6K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$116.7M)
Spyre Therapeutics, Inc.
Shares:70.0K
Value:$1.1M
% of Portfolio:1.0% ($1.1M/$116.7M)
Apogee Therapeutics, Inc.
Shares:30.0K
Value:$1.1M
% of Portfolio:1.0% ($1.1M/$116.7M)
Praxis Precision Medicines, Inc.
Shares:19.0K
Value:$719.5K
% of Portfolio:0.6% ($719.5K/$116.7M)
89bio, Inc.
Shares:95.6K
Value:$695.2K
% of Portfolio:0.6% ($695.2K/$116.7M)
Oruka Therapeutics, Inc.
Shares:58.2K
Value:$597.3K
% of Portfolio:0.5% ($597.3K/$116.7M)
221015950
Shares:90.0K
Value:$286.2K
% of Portfolio:0.2% ($286.2K/$116.7M)